Edition:
India

Santen Pharmaceutical Co Ltd (4536.T)

4536.T on Tokyo Stock Exchange

1,796JPY
11:30am IST
Change (% chg)

¥-8 (-0.44%)
Prev Close
¥1,804
Open
¥1,782
Day's High
¥1,796
Day's Low
¥1,767
Volume
1,002,900
Avg. Vol
1,303,210
52-wk High
¥1,946
52-wk Low
¥1,343

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold 21.17 March 17 Jan 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 1 1
(2) OUTPERFORM 4 4 4 4
(3) HOLD 6 6 5 5
(4) UNDERPERFORM 1 1 2 2
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.73 2.73 2.67 2.67

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 1 55,000.00 55,000.00 55,000.00 --
Quarter Ending Sep-18 1 54,900.00 54,900.00 54,900.00 --
Year Ending Mar-18 10 219,771.00 225,310.00 206,000.00 209,700.00
Year Ending Mar-19 10 228,406.00 237,757.00 212,000.00 218,175.00
Earnings (per share)
Quarter Ending Jun-18 1 21.17 21.17 21.17 --
Quarter Ending Sep-18 1 20.43 20.43 20.43 --
Year Ending Mar-18 11 71.19 80.42 65.50 69.98
Year Ending Mar-19 11 75.78 87.16 60.60 77.72
LT Growth Rate (%) 2 10.18 13.27 7.10 -12.35

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 52,350.70 54,825.00 2,474.33 4.73
Quarter Ending Jun-17 52,734.00 55,949.00 3,215.00 6.10
Quarter Ending Mar-17 51,473.00 48,429.00 3,044.00 5.91
Quarter Ending Dec-16 52,375.00 52,838.00 463.00 0.88
Quarter Ending Sep-16 45,947.00 47,823.00 1,876.00 4.08

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 55,000.00 55,000.00 55,000.00 55,000.00 --
Quarter Ending Sep-18 54,900.00 54,900.00 54,900.00 55,200.00 --
Year Ending Mar-18 219,771.00 219,771.00 219,331.00 218,206.00 209,700.00
Year Ending Mar-19 228,406.00 228,706.00 228,096.00 227,582.00 218,175.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 0
Quarter Ending Sep-18 0 0 0 0
Year Ending Mar-18 0 0 1 0
Year Ending Mar-19 0 1 1 1
Earnings